hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia
2022 · Cell Reports Medicine · 19 citations
https://doi.org/10.1016/j.xcrm.2022.100717
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
35
Citations
3
h-index
1
i10-index
Sharon Angel is an academic researcher from Newcastle University. The author has contributed to research in topics: Mesenchymal stem cell research & Cancer Cells and Metastasis & Mosquito-borne diseases and control. The author has an h-index of 3, co-authored 4 publications.
Click to start Chat